Photo by Adam Śmigielski on Unsplash
Photo by Unsplash
What Happened — June 28, 2026
$2 billion. That is what OpenAI collects every single month — and yet, as of late June 2026, the company most closely identified with the generative AI era is signaling to its bankers: not yet.
The New York Times, citing three people involved in the company's internal deliberations, reported on June 25, 2026 that OpenAI is leaning toward postponing its public market debut until 2027. This follows the company's confidential S-1 registration statement (the formal document companies submit to regulators before going public) filed with the SEC on June 8, 2026 — a date confirmed by CNBC — which had previously suggested a Q3/Q4 2026 listing window. Bloomberg confirmed the NYT report and contributed a clarifying detail: advisers presented OpenAI executives with two options — accept a lower valuation for a 2026 listing, or hold out for the $1 trillion target in 2027. According to Bloomberg, CEO Sam Altman called any valuation reduction a "non-starter."
According to Google News, which aggregated coverage across multiple outlets, the timing shift is directly tied to SpaceX's June 12, 2026 market debut — the largest IPO in history, with shares listing at $150 on Nasdaq and a market valuation exceeding $2 trillion. Subsequent share price volatility alarmed OpenAI's lead underwriters Goldman Sachs and Morgan Stanley about retail investor appetite for high-burn technology companies. JPMorgan Chase is also involved in the preparation.
The Bull Case — $852 Billion Isn't Hype, It's Institutional Conviction
Thesis: OpenAI's $122 billion March 2026 funding round at an $852 billion post-money valuation — anchored by Amazon ($50 billion), SoftBank ($30 billion), and Nvidia ($30 billion) — reflects deep institutional conviction in OpenAI's enterprise dominance, but the IPO delay signals that even the bulls agree the public market is not currently positioned to price that conviction at scale.
The commercial traction is real. As of June 28, 2026, OpenAI generates $2 billion in monthly revenue — roughly $24–25 billion annualized — with enterprise customers comprising over 40% of that figure. The March 2026 round also marked the first time OpenAI raised from retail investors, pulling in $3 billion from non-institutional participants. Wedbush Securities analyst Dan Ives stated that OpenAI's S-1 filing shows "the floodgates for the IPO market are officially open," and the macro environment supports a receptive window: through May 31, 2026, the tech IPO market had raised $34.2 billion — up 163.9% year-over-year — across 79 filed deals, with a total of 113 IPOs by mid-year representing a 10.5% increase from 2025. Kalshi prediction market traders, as of late June 2026, assign a 59% probability that OpenAI will officially announce an IPO by March 1, 2027.
Chart: OpenAI's annualized revenue run rate ($24B) versus projected 2026 net losses ($14B), illustrating the gap between commercial scale and path to profitability. Source: Research data compiled as of June 28, 2026.
The Bear Case Deserves Better Than a Paragraph
The skeptical case against OpenAI at a trillion-dollar valuation is not simply "they are losing money." It is a structural argument about whether the unit economics of frontier AI development can ever converge to the margins that public market shareholders require — and it deserves to be argued with specifics.
Start with the cash burn. OpenAI expects to lose $14 billion in 2026 alone. HSBC analysts estimate the company may need over $207 billion in additional funding by 2030 just to sustain operations, with cumulative losses potentially reaching $44 billion before any path to profitability — a timeline the company itself does not project before 2029–2030. EMARKETER principal analyst Nate Elliott has described the filing as coming "at a precarious moment." Skeptical analysts note that no company has ever justified a trillion-dollar price tag while burning $27 billion a year in operating costs.
Then there is competitive compression. Anthropic — OpenAI's primary rival — confidentially filed for IPO in June 2026 following a $65 billion Series H round that valued the company at $965 billion. Two near-trillion-dollar AI companies pursuing public capital in overlapping windows is not a sign of category scarcity; it creates direct institutional allocation pressure that could constrain pricing for both. Investors are watching which company blinks first on its valuation target.
Add a regulatory wildcard: Reuters reported that the Trump administration requested OpenAI stagger the release of its upcoming AI model over national security concerns. Product velocity constraints are precisely the kind of exogenous risk that complicates the revenue growth projections underpinning any trillion-dollar thesis. OpenAI also committed to over $1.4 trillion in data center and infrastructure spending over coming years — a capital commitment structurally incompatible with the free cash flow (profit remaining after operating expenses and capital investment) generation that public market shareholders typically reward. The same AI-driven disruption fueling OpenAI's revenue growth also raises structural labor market questions — as Stanford research on entry-level job displacement has documented — that may eventually reshape enterprise AI demand in ways that are difficult to model from the outside.
Watchlist — Investment Research Checklist for the AI IPO Wave
For investors conducting their own sector analysis on the AI IPO landscape, the specific metrics worth tracking:
- S-1 amendments (public filing): OpenAI's confidential S-1 filed June 8, 2026 becomes a public document when the company files amendments ahead of the IPO. Gross margin and customer acquisition cost disclosures will be the first real stress test of the trillion-dollar valuation argument — and the most important numbers in this entire story.
- Monthly revenue trajectory: The $24–25 billion annualized run rate matters less than its rate of change. Any deceleration before the IPO window opens would likely force a valuation renegotiation that Altman has so far refused.
- Anthropic's IPO move: A public Anthropic listing at or near its $965 billion private valuation sets a benchmark — validating if the market rewards it, constraining if it prices at a meaningful discount.
- Kalshi probability marker: Prediction markets currently assign a 59% probability of an official IPO announcement by March 1, 2027. Direction of movement in coming months functions as a real-time investor sentiment gauge on the timeline.
- Adjacent tickers: Microsoft (MSFT — commercial partner), Nvidia (NVDA — $30 billion investor and primary compute supplier), and SoftBank (9984.T — $30 billion investor) all carry meaningful exposure to OpenAI's outcome before any public listing exists.
Frequently Asked Questions
Can I buy OpenAI stock now, and is the IPO worth investing in at the current valuation?
As of June 28, 2026, OpenAI shares are not publicly traded. Pre-IPO access exists through secondary markets where employees and early investors may sell shares, but minimum thresholds are typically high and liquidity is extremely limited. Investment research on the situation frames any position as highly speculative: the combination of $14 billion in projected 2026 losses, a $207 billion estimated funding gap through 2030, and a profitability timeline not projected until 2029–2030 creates risk uncommon even among high-growth tech listings. Independent analysts suggest that if the AGI (artificial general intelligence) vision resonates with your research, allocating no more than 1–3% of a portfolio is worth researching further — but this is a position to size carefully, not chase.
When is OpenAI expected to go public, and what is the likely IPO valuation?
According to reporting by The New York Times and confirmed by Bloomberg as of June 25, 2026, OpenAI is leaning toward a 2027 IPO rather than a late 2026 debut. CEO Sam Altman is targeting a $1 trillion valuation and has reportedly rejected any reduction as a "non-starter." The company's most recent private round — completed in March 2026 — placed its post-money valuation at $852 billion, meaning Altman is seeking roughly a $148 billion step-up from the last private round to justify waiting an additional year.
How does the OpenAI IPO compare to SpaceX and the broader 2026 tech IPO market?
SpaceX completed what research data identifies as the largest IPO in history on June 12, 2026, listing at $150 per share on Nasdaq and exceeding $2 trillion in market value. The broader tech IPO market raised $34.2 billion through May 31, 2026 — up 163.9% year-over-year — across 79 filed deals, with 113 total IPOs through mid-year representing a 10.5% increase from 2025. OpenAI's delay was partly driven by SpaceX's post-IPO share price volatility, which OpenAI's bankers cited as evidence that retail investors remain selective about high-burn companies even in a recovering environment. Investors are watching whether Anthropic's concurrent IPO filing — at a $965 billion private valuation — clarifies or complicates public pricing for frontier AI companies.
Bottom line: OpenAI's IPO delay is a calculated patience play, not a distress signal. The bull case — $24 billion in annualized revenue, a $122 billion institutional funding round at an $852 billion post-money valuation, and category-defining enterprise traction — is empirically grounded. So is the bear case: $14 billion in 2026 losses, a $207 billion projected funding gap through 2030, and a valuation argument without clear historical precedent. In my analysis, the most important variable is not the IPO date but what the public S-1 amendments reveal about gross margins. When I review the full picture, I would argue Altman's trillion-dollar stand is defensible only if those margins, when disclosed, show a credible path toward the 60–70% range that would make the revenue multiple rational at scale. Until then, investors are watching — and waiting — for the same thing he is.
Disclaimer: This article is for educational and informational purposes only and represents original editorial commentary based on publicly reported facts. It does not constitute financial advice, a recommendation, or an endorsement of any security. Always conduct your own research and consult a licensed financial advisor before making investment decisions. Research based on publicly available sources current as of June 28, 2026.